Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome

Cristina Solé, Ann T. Ma, Elsa Solà, Marta Carol, Núria Fabrellas, Adrià Juanola, Laura Napoleone, Jordi Gratacós-Ginès, Octavi Bassegoda, Marta Cervera, Martina Pérez, Ana Belén Rubio, Emma Avitabile, Manuel Morales-Ruiz, Isabel Graupera, Elisa Pose, Patrick S. Kamath, Pere Ginès

Research output: Contribution to journalArticlepeer-review


Whether tubular injury develops in patients with acute kidney injury owing to hepatorenal syndrome (AKI-HRS) is controversial. We performed repeated measurements of biomarkers of tubular injury during a 14-day period in 60 patients with cirrhosis and AKI (34 with AKI-HRS meeting the classical definition of type 1 HRS and 26 with AKI owing to acute tubular necrosis, AKI-ATN). Nineteen of 34 patients had resolution of AKI-HRS, while the remainder had persistent AKI-HRS. The persistence of AKI-HRS was associated with remarkably high short-term mortality. There were no significant differences in urinary NGAL or IL-18 between patients with resolution vs those with persistent AKI-HRS throughout the 14-day period. By contrast, biomarker levels were significantly lower in AKI-HRS, even if persistent, compared to AKI-ATN. These findings are highly suggestive of lack of significant tubular injury in AKI-HRS and could be of value in the clinical decision between combined liver–kidney or liver transplantation alone in patients with cirrhosis and AKI candidates to transplantation.

Original languageEnglish (US)
Pages (from-to)2729-2732
Number of pages4
JournalLiver International
Issue number11
StatePublished - Nov 2021

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome'. Together they form a unique fingerprint.

Cite this